Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Minling Liu"'
Autor:
Huiru Dai, Minling Liu, Xueying Li, Tingwei Li, Wensheng Huang, Jiehao Liao, Yun Li, Shuo Fang
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Background The prognosis of patients under existing neoadjuvant chemotherapy or neoadjuvant chemoradiotherapy requires improvement. Whereas programmed cell death 1 (PD-1) inhibitors have shown promising response in advanced esophageal cancer
Externí odkaz:
https://doaj.org/article/4b97d66a00aa4371a6e42f692d163971
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The current study aimed to construct a prognostic predictive model based on tumor microenvironment. CIBERSORT and ESTIMATE algorithms were used to reveal the immune cell infiltration (ICI) landscape of colon cancer. Patients were classified into thre
Externí odkaz:
https://doaj.org/article/cba85adf90154d948d71f6ff4949874b
Publikováno v:
Carbon. 197:341-349
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24fcc7a389a9d68519bcf8dc1d1ab2f9
https://doi.org/10.1016/j.carbon.2022.06.043
https://doi.org/10.1016/j.carbon.2022.06.043
Publikováno v:
Expert Review of Hematology. 15:657-665
Acute myeloid leukemia (AML) is a hematological malignancy with highly clinical heterogeneity resulting in poor outcomes. We aim to identify novel prognostic lncRNA in AML expecting to provide new clues for therapy in AML.Three cohorts were enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4d6ef4ac1ed7e56490fae4a28951a7b
https://doi.org/10.1080/17474086.2022.2091542
https://doi.org/10.1080/17474086.2022.2091542
Publikováno v:
Medical Research. 3:15-32
Purpose: TNBC with germline BRCA1/2 mutation (gBRCAm) have higher sensitivity to DNA damaging agents including platinum-based chemotherapy and PARP inhibitors. But the treatment of TNBC without gBRCAm remains challenging. This study aimed to develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5256b89b49849a55eff7b5eca9db18
https://doi.org/10.6913/mrhk.202109_3(3).0003
https://doi.org/10.6913/mrhk.202109_3(3).0003
Publikováno v:
Expert review of anticancer therapy. 22(8)
Acute myeloid leukemia (AML) is a common hematologic malignancy with high heterogeneity and poor prognosis. Although long non-coding RNAs (lncRNAs) have been used as biomarkers for tumors, the clinical relevance of numerous lncRNAs in AML remains to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::908a358f5a73b48201039d816e240c90
https://pubmed.ncbi.nlm.nih.gov/35894677
https://pubmed.ncbi.nlm.nih.gov/35894677
Autor:
Shuo Fang, Yuchen Liu, Zhe-Sheng Chen, Ruixiang Guo, Huiru Dai, Fuweijian Liu, Minling Liu, Xueying Li, Tingwei Li, Jiehao Liao
Publikováno v:
Recent patents on anti-cancer drug discovery.
Background: Lymphoid Enhancer-Binding Factor-1 (LEF1) was previously reported to contribute to a variety of malignancies, including Hepatocellular Carcinoma (HCC). However, its role in HCC is poorly understood. Objective: To explore the role of LEF1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bae60dccdda461e99e01990e94ba1f9
https://pubmed.ncbi.nlm.nih.gov/36045537
https://pubmed.ncbi.nlm.nih.gov/36045537
Autor:
Tingwei Li, Minling Liu, Huiru Dai, Xueying Li, Jiehao Liao, Zilong Zheng, Yihang Pan, Yuchen Liu, Shuo Fang
Publikováno v:
Journal of oncology. 2022
Objective. To investigate the association of the plasma level of cytokines and blood routine indexes with clinical characteristics in patients with cancer. Methods. We analyzed plasma samples derived from 134 cancer patients. Interleukins (IL) 1β, 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070e64df7ad3dca7abbe97f917239227
https://pubmed.ncbi.nlm.nih.gov/36157224
https://pubmed.ncbi.nlm.nih.gov/36157224
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundTumor microenvironment consists of tumor cells, immune cells and other matric components. Tumor infiltration immune cells are associated with prognosis. But all the current prognosis evaluation system dose not take tumor immune cells other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cb4ffa57f0e1580100db69e0be17b2c
https://www.frontiersin.org/articles/10.3389/fonc.2021.728842/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.728842/full
Autor:
Huiru Dai, Zhe-Sheng Chen, Shuo Fang, Lei Li, Minling Liu, Yihang Pan, Xiaofen Pan, Shan Huang
Publikováno v:
Recent patents on anti-cancer drug discovery. 17(4)
Background: Triple-negative breast cancer (TNBC) is a highly aggressive malignancy with a poor prognosis. Therefore, it is imperative to develop new prognostic or therapeutic biomarkers for TNBC. Objective: To explore the prognostic and therapeutic v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::852b05aa6f9a8e08c84f499053f7319d
https://pubmed.ncbi.nlm.nih.gov/34847851
https://pubmed.ncbi.nlm.nih.gov/34847851